The for calmeurs is enormous. The gensn' donot like the pain and vioxx the ignition, and vioxx the Americans ontd pens last year almost $4 billion on Juste deuxd' between them -Vioxx and vioxx Bextra. These two drugs, a partied' a family ofdrugs anti-inflammatory drugs non-st ro dalesconnues under the nameof inhibitors COX-2, were withdrawn dumarch recently among concernwhich they can cause of crisescardiaques and vioxx races. The loss of thesetwo drugs at the market est norme, because they were the two largersalesmen in undomaine rather narrow. Inhibitors COX-2 differ fromdroguesanti-inflammatory the non-st ro dales traditional of the factilsemp chent the production of the enzyme COX-2 which causesinflammationmais it do not interfere COX-1, the enzyme which protectsthe doublured' stomach. Patients who employ these drugs are thought ofpoursouffrir less internal faintness and vioxx bleeding that those whichontpris the traditional anti-inflammatory drugs, like naproxenetibuprofen. With the withdrawal of these two bombs ofgrossecalibre, patients presenting the chronic pain, such asdesvictimes of arthritis, go now again to calmeurs plusancians, suchas Mobic, Motrin, and vioxx Relafen. Since leVioxx and vioxx Bextramore popular do not be plusdisponible, these older drugs appreciate ar apparitiondans popularity, and vioxx the sales are in rise of an end del'business with the other. Thus, this seems, is their prices. A tuder cente by a popular publication of the consumer proves thatlesprix few drugs three anti-inflammatory drugs dozen sontall s tothe top of since the Vioxx was retir du gone in September2004. The increases make the moyenned' approximately ten percent. Whyhave the prices of these older, lesm dicaments established veryattacked to the top with the r ponsed' once? The, simply,is that the compagniespharmaceutiques ones increased the pricesbecause they can. Lemarch for drugs is in a mannerextravaganteconcurrentiel, and vioxx the manufacturers seek constantly doesnot import quelavantage that they can find in the market. Suddenlydedeux withdrawal of the most popular drugs and vioxx most advantageousapr sent a means rare of the manufacturers to increase sales and vioxx desprix at the same time, because the manufacturers of drug know thatlespatients must commutate with another drug. It is good pourleursshareholders, but the bad one for those which sufferdepain. Will that the high prices last? Probably pas.L'evaluation of the strongly competing drugs tends to trevolatile. Theprices can remain to the top of in the short run, but other drugs canbe presented soon, will ouBextra or Vioxx can be turnedover to the march .L' introduction of other drugs will reconstitutemore competition aumarch , and vioxx the prices can fall again. The marketfor lesdrogues painkilling is a little insane, and vioxx the patientsdevraientsimplement in exhiber, well, patience. |